Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 4.34 HKD 2.84% Market Closed
Market Cap: 19.8B HKD
Have any thoughts about
Shandong Weigao Group Medical Polymer Co Ltd?
Write Note
Shandong Weigao Group Medical Polymer Co Ltd
/
Income Statement
/
Other Operating Expenses

Shandong Weigao Group Medical Polymer Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Weigao Group Medical Polymer Co Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Other Operating Expenses
¥370.4m
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Other Operating Expenses
¥5.4m
CAGR 3-Years
35%
CAGR 5-Years
9%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Other Operating Expenses
-¥26.6m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Autobio Diagnostics Co Ltd
SSE:603658
Other Operating Expenses
¥59.1m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Other Operating Expenses
¥97m
CAGR 3-Years
12%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Other Operating Expenses
¥32.3m
CAGR 3-Years
32%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Shandong Weigao Group Medical Polymer Co Ltd
Glance View

Market Cap
19.8B HKD
Industry
Health Care

Nestled in the bustling industrial heart of China, Shandong Weigao Group Medical Polymer Co Ltd stands as a testament to the transformative potential within the field of medical devices. Since its inception in 1988, Weigao has diligently carved out a niche within the healthcare sector, specializing in the production and distribution of medical consumables, orthopedic materials, and blood purification apparatus. The company's journey is intertwined with China's healthcare evolution, as it became a critical player in supplying hospitals and medical institutions with essential, reliable tools. By leveraging advancements in polymer science, Weigao consistently pushes the boundaries in creating high-quality, cost-effective products—a maneuver that not only reduces healthcare costs but also ensures widespread accessibility to essential medical supplies. Driven by an intricate understanding of the medical landscape, Weigao's operational model hinges on its robust vertical integration strategy. The company effectively controls every stage of its production process, from raw material procurement to product manufacturing and distribution. This control not only ensures stringent quality checks but also allows for improved economies of scale, thereby boosting its profitability margins. Revenue streams largely stem from its extensive product lineup, which includes syringes, blood bags, infusion sets, and orthopedic devices, catering to domestic demand while also penetrating international markets. The constant stream of innovations, coupled with an expanding global footprint, underscores Weigao's commitment to growth, firmly positioning it as a stalwart in the medical apparatus industry.

Intrinsic Value
8.37 HKD
Undervaluation 48%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shandong Weigao Group Medical Polymer Co Ltd's Other Operating Expenses?
Other Operating Expenses
370.4m CNY

Based on the financial report for Jun 30, 2024, Shandong Weigao Group Medical Polymer Co Ltd's Other Operating Expenses amounts to 370.4m CNY.

What is Shandong Weigao Group Medical Polymer Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
2%

Over the last year, the Other Operating Expenses growth was 31%. The average annual Other Operating Expenses growth rates for Shandong Weigao Group Medical Polymer Co Ltd have been 8% over the past three years , 2% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 215,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.